Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
vesiculobullous skin diseases
MeSH D012872 - vesiculobullous skin diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012871:
Skin diseases
36 Companies
17 Drugs
$
Success rate
D012872:
Vesiculobullous skin diseases
0 Companies
0 Drugs
Success rate
D000051:
Acantholysis
0 Companies
0 Drugs
Success rate
D001768:
Blister
5 Companies
1 Drug
$
Success rate
D003874:
Dermatitis herpetiformis
132 Companies
19 Drugs
$
Success rate
D004820:
Epidermolysis bullosa
1 Company
1 Drug
$
Success rate
D004892:
Erythema multiforme
119 Companies
15 Drugs
$
Success rate
D006559:
Pemphigoid gestationis
0 Companies
0 Drugs
Success rate
D006837:
Hydroa vacciniforme
0 Companies
0 Drugs
Success rate
D010390:
Benign mucous membrane pemphigoid
0 Companies
0 Drugs
Success rate
D010391:
Bullous pemphigoid
1 Company
1 Drug
$
Success rate
D010392:
Pemphigus
131 Companies
21 Drugs
$
Success rate
D011146:
Dyshidrotic eczema
0 Companies
0 Drugs
Success rate
D016506:
Benign familial pemphigus
0 Companies
0 Drugs
Success rate
D062027:
Linear iga bullous dermatosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
0
%
0/0
Approved:
0
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use